Cumberland Pharmaceuticals Inc CPIX:NASDAQ

Last Price$2.05NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/29/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$1.96 (1)
Ask (Size)$2.15 (5)
Day Low / HighN/A - N/A
Volume7.3 K

View Pharmaceuticals: Major IndustryPeer Comparison as of 06/29/2022


Cumberland Pharmaceuticals Inc ( NASDAQ )

Price: $2.05
Change: +0.01 (0.49%)
Volume: 7.3 K
4:00PM ET 6/29/2022

Mannatech Inc ( NASDAQ )

Price: $15.60
Change: -0.60 (3.70%)
Volume: 4.8 K
3:56PM ET 6/29/2022

NeuBase Therapeutics Inc ( NASDAQ )

Price: $0.93
Change: +0.07 (8.69%)
Volume: 95.5 K
4:00PM ET 6/29/2022

Adial Pharmaceuticals Inc ( NASDAQ )

Price: $1.25
Change: +0.13 (11.61%)
Volume: 317.00
4:00PM ET 6/29/2022

Regulus Therapeutics Inc ( NASDAQ )

Price: $2.10
Change: +0.06 (2.94%)
Volume: 915.00
4:00PM ET 6/29/2022

Read more news Recent News

-- Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q1 EPS $0.03
4:25PM ET 5/10/2022 MT Newswires


-- Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Posts Q1 Revenue $11.2M
4:24PM ET 5/10/2022 MT Newswires


Cumberland Pharmaceuticals Swings to Loss in Q4 Amid Lower Revenue
5:05PM ET 3/08/2022 MT Newswires

Cumberland Pharmaceuticals (CPIX) on Tuesday reported an adjusted loss of $0.13 per share in Q4, reversing from an adjusted profit of $0.01 a year earlier,...

-- Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q4 Revenue $8.3M
4:10PM ET 3/08/2022 MT Newswires


Company Profile

Business DescriptionCumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, and RediTrex. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN. View company web site for more details
Address2525 West End Avenue
Nashville, Tennessee 37203
Number of Employees80
Recent SEC Filing06/10/20224
Chairman & Chief Executive OfficerA. J. Kazimi
Chief Financial & Accounting OfficerJohn M. Hamm
Chief Compliance Officer & Senior Vice PresidentJames L. Herman
Executive Director-Organizational DevelopmentTodd Anthony

Company Highlights

Price Open$2.07
Previous Close$2.05
52 Week Range$1.89 - 7.51
Market Capitalization$30.3 M
Shares Outstanding14.8 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/09/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.37
Beta vs. S&P 500N/A
Revenue$40.7 M
Net Profit Margin-17.91%
Return on Equity-14.69%

Analyst Ratings as of 03/19/2021

Consensus RecommendationConsensus Icon
Powered by Factset